Showing results (81-90 of 10,874) with videos related to
Sort By:
Pageof 1,088
Breast Cancer Research and Treatment|May 21, 2003
HER-2/neu and topoisomerase IIalpha in breast cancerTero A H Järvinen, Edison T LiuBreast Cancer Research and Treatment|May 21, 2003
Genome amplification of chromosome 20 in breast cancerJ Graeme Hodgson, Koei Chin, Colin Collins, et al.Breast Cancer Research and Treatment|November 10, 2021
Safety of autologous fat grafting in breast cancer: a multicenter Italian study among 17 senonetwork breast units autologous fat grafting safety: a multicenter Italian retrospective studyMarco Klinger, Agnese Losurdo, Andrea V E Lisa, et al.Breast Cancer Research and Treatment|November 10, 2021
Breast cancer outcomes following immediate breast reconstruction with implants versus autologous flaps: a propensity score-matched studyZhen-Yu Wu, Jing Han, Hee Jeong Kim, et al.Breast Cancer Research and Treatment|March 19, 2021
A qualitative study to evaluate physician attitudes regarding omission of surgery among exceptional responders to neoadjuvant systemic therapy for breast cancer (NRG-CC006)Laila A Gharzai, Lauren A Szczygiel, Dean A Shumway, et al.Breast Cancer Research and Treatment|November 16, 2021
Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict)Paul Jank, Judith Lea Lindner, Annika Lehmann, et al.Breast Cancer Research and Treatment|November 29, 2021
Factors related to patient-reported cosmetic outcome after breast-conserving therapy for breast cancerA T P M Brands-Appeldoorn, R C M Thomma, L Janssen, et al.Breast Cancer Research and Treatment|December 2, 2021
Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testingPhuong Dinh, J Dinny Graham, Elisabeth N Elder, et al.Breast Cancer Research and Treatment|November 26, 2021
Predicting the clinical outcomes and benefit from letrozole after 5 years of treatment with aromatase inhibitors for early breast cancer: analysis from CCTG MA.17RYapeng Li, Xueying Zheng, Dongsheng Tu, et al.Breast Cancer Research and Treatment|November 23, 2018
The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysisKirsty Wai Chung Lee, Sally Lord, Richard S Finn, et al.Pageof 1,088